Male Genital Enhancement in 2026: Options, Pricing, and What’s Safe

Male Genital Enhancement in 2026: Cutting Through the Noise

Most men who search for “male genital enhancement” have not yet chosen a procedure. They want to understand what is available, what is legitimate, and what it costs before they commit to a consultation. For many high-achieving professionals, this research happens quietly, often after years of assuming no credible solution existed.

That caution makes sense. Male enhancement marketing has a long history of overpromising, and overseas clinics and medical-tourism operators have taken advantage of the resulting distrust with vague claims and unregulated pricing. Men looking for clear answers usually find sales pitches instead.

This guide is designed to help with that decision. It organizes every major option by anatomical target (shaft/girth, glans, scrotum) and by strength of evidence, so readers can find the resource that fits their goals. It covers four things:

• Transparent US pricing, including how treatment is actually billed
• FDA clearance and off-label status for every modality discussed
• A clear safety hierarchy based on medical-society guidance
• An explanation of why surgical lengthening is excluded from the practice’s offerings

This is a mainstream category of care. According to Penis Enlargement New York City (operated by Stoller Medical Group), male cosmetic procedures have grown roughly 500% over the past 25 years, rising from about 3% to over 15% of all cosmetic patients. This page functions as a hub, linking readers to dedicated procedure, cost, and before/after resources rather than repeating that depth here.

The Three Anatomical Targets of Male Genital Enhancement

Much of the misinformation in this field comes from treating shaft, glans, and scrotal enhancement as one procedure. They are distinct anatomical targets, and each has its own techniques, risk profile, and evidence base.

This taxonomy matters more than comparing brand names. A patient’s goal (more girth, better head proportion, or scrotal smoothness and fullness) decides which modalities are relevant at all. Cost and technique come after that.

Shaft and Girth Enhancement

This is the largest and most studied sub-category. It includes injectable fillers, fat grafting, and implants such as Penuma.

Girth augmentation has far more clinical research behind it than lengthening does. An NIH-registered clinical trial (NCT04755634) studied Juvederm Voluma XC and Vollure XC and reported a mean girth increase of 2.83 cm at one-year follow-up (n=17, p<0.0001). Across published studies, girth increases range from about 2.1 to 3.8 cm, depending on the filler type and study design. That range is a realistic baseline for expectations.

Glans Enhancement

Glans enhancement is a smaller, distinct procedure. It is usually performed alongside shaft treatment to improve the proportion and appearance of the head.

Clinical opinion is divided here. Some urologists remain cautious because long-term studies with reproducible results are limited. Others point to accumulating safety data and growing patient demand. Any provider who presents glans enhancement as settled science is overselling it.

Scrotal Enhancement

Scrotal enhancement is a fast-growing sub-category that often gets overlooked. It includes filler-based scrotal augmentation, which changes the size, shape, and tension of the scrotal skin, and Scrotox, which uses botulinum toxin.

The mechanism behind Scrotox is simple. It relaxes the tunica dartos, the muscle layer that forms the scrotal folds and wrinkles while regulating testicular temperature. Once relaxed, the skin appears smoother, and the testicles hang lower and look fuller.

Interest has risen alongside social media and online “optimization” culture. The practice approaches the topic clinically rather than following trends.

Evidence Tiers: Grading Each Option by What the Science Actually Shows

Most competitors present every option as equally validated. A more honest approach ranks each technique by the strength of its clinical data.

Newer or more dramatic options are not necessarily better studied. Readers can use these tiers to set expectations before looking at any specific procedure page.

FDA Clearance and Off-Label Status: What’s Actually Approved for This Use

This is the core of the trust problem in this field. No soft-tissue filler (HA, PLA, or PMMA) has specific FDA approval for penile enhancement. All filler use in this area is off-label, even when the material itself is FDA-approved for other indications.

Off-label use is common and legal in medicine. However, patients paying out of pocket for a cosmetic procedure should understand this distinction before they commit.

Hyaluronic Acid (HA) Filler

Status: FDA-approved as a dermal filler. Used off-label for penile, glans, and scrotal enhancement.

HA’s main safety advantage is that it is reversible. If a patient is dissatisfied or has a complication, the filler can be dissolved with hyaluronidase. No permanent filler or implant offers that option. HA is placed in the dartos layer beneath the penile skin, and results typically last 18 to 24 months.

The supporting data is consistent:

• The NCT04755634 trial reported a 2.83 cm mean gain at one year.
• The Kwak and Ahn cohorts reported gains of 2.3 to 3.8 cm. Mild inflammation was the most common complication (6.3% in one cohort).
• A 2020 head-to-head trial found gains of 2.1 cm with HA versus 1.6 cm with PLA at 24 weeks. PLA has also been linked to foreign body granulomas in some patients.

The practice’s primary product, Belefil®, is described as a medical-grade, hyaluronic acid-based filler designed for soft tissue augmentation.

PMMA (Polymethyl Methacrylate) Microspheres

Status: FDA-approved for certain cosmetic indications. Off-label for penile use. Permanent and non-reversible.

A 752-patient series spanning seven years reported average girth gains of 3.5 cm after one to three sessions. However, roughly half of patients developed implant irregularities, and 52% reported nodularity, ridges, or indentations. The Sexual Medicine Society of North America (SMSNA) strongly recommends against permanent fillers for penile enhancement, which applies directly to PMMA.

Penuma Implant

Status: The only FDA 510(k)-cleared subcutaneous silicone implant referenced in cosmetic penile enhancement marketing. The scope of that clearance is disputed.

Manufacturer-reported data shows average mid-shaft girth increases of about 56.7% (3.0 cm) and flaccid length increases of about 44% (2.5 cm).

The regulatory dispute is significant. Class-action litigation alleges that Penuma was cleared only for correcting soft-tissue deformities such as those associated with Peyronie’s disease, not for cosmetic enlargement. The 2025 federal case Gonzalez v. International Medical Devices centers on allegations that Penuma marketing gives consumers the false impression that the FDA found the device safe and effective for cosmetic use. Most competitor sites leave this out, but patients should know about it.

Fat Grafting

Status: Autologous fat is not an FDA-regulated device. The AUA and Urology Care Foundation explicitly state that fat injection for girth “has not been shown to be safe or efficacious.”

The risk is real. A published case report documents a fatal fat embolism in a 30-year-old man after aesthetic penile fat injection. This is a key reason the practice does not perform fat grafting for genital enhancement.

Scrotox (Botulinum Toxin)

Status: Botulinum toxin is FDA-approved for many indications. It is off-label when injected into the scrotum for cosmetic smoothing.

Reported risks include bruising, swelling, infection, asymmetry, and general dissatisfaction. Results are temporary because the effects of botulinum toxin fade over several months. Long-term aesthetic research is limited, which is why Scrotox sits in Tier 4.

What These Procedures Actually Cost in 2026

Many practices withhold pricing until a sales consultation. This practice discloses its pricing structure upfront.

Pricing starts at $7,500 and increases based on the number of syringes needed to achieve the desired result. Most men begin with a minimum of 10 syringes, and the average first procedure uses 15 syringes. Total cost therefore depends on the results a patient wants rather than a flat fee.

Final cost depends on several factors:

• Anatomy and starting dimensions
• Goals, ranging from subtle refinement to the maximum volume that can be added safely
• Combined treatment, such as adding glans or scrotal enhancement in the same session

Category-wide benchmarks provide context:

None of these procedures are covered by insurance. Because they are cash-pay cosmetic services, a provider’s complication rate and reputation matter even more.

Why US, Board-Certified Pricing Is Worth the Premium

Medical-tourism clinics in Turkey and Mexico compete heavily on price. They list Penuma at $4,500 to $16,000, compared with $15,000 to $25,000+ in the US.

The price difference pays for specific protections:

• Board-certified physician oversight throughout treatment
• Hospital-grade sterility and infection-prevention protocols
• Device traceability and warranty support
• Follow-up care in the same jurisdiction where the procedure was performed

Overseas savings can also disappear quickly. Complications from procedures performed abroad often require correction in the US, and the combined cost frequently exceeds what appropriate care would have cost in the first place. Experience also affects outcomes. The practice has performed more than 15,000 enlargement procedures, and that volume and continuity of care help avoid the complications documented in less experienced or unregulated settings.

This connects back to the FDA discussion. In unregulated settings, patients often cannot verify where materials come from, whether a device is legitimate, or what its clearance status is.

Who Should (and Shouldn’t) Consider These Procedures

One finding changes how this decision should be viewed. Across clinical cohorts, genuinely below-average anatomy is rare among men seeking augmentation. Most have objectively normal-sized anatomy.

Surveys show a clear perception gap. 84% of female partners report satisfaction with their partner’s size, compared with only 55% of men who are satisfied with their own, and 45% who want to be larger. For most men, enhancement is a decision about confidence rather than a medical necessity.

For that reason, responsible providers screen candidates psychologically. Guidance from the European Association of Urology (EAU) and the SMSNA calls for screening for small penis syndrome and body dysmorphic disorder, and for confirming that expectations are realistic, before any treatment. Most commercial competitor pages do not mention this.

The only universally recognized medical indication for surgery is micropenis, defined as a stretched length under 7.5 cm. This page mainly addresses the elective, confidence-driven majority. The practice’s safety-first philosophy means a thorough consultation and goal-setting happen before any procedure is booked.

Why This Practice Does Not Offer Surgical Penile Lengthening

Surgical lengthening (ligament release or ligamentolysis) is intentionally excluded from the practice’s service menu.

The AUA and Urology Care Foundation state that dividing the suspensory ligament for length has “not been shown to be safe or efficacious.” The procedure carries risks of instability, scarring, and functional complications, and it does not reliably produce durable results.

Many other clinics market this procedure, and declining to offer it likely means lost revenue. The practice considers the risk-benefit profile unfavorable and focuses instead on filler-based shaft, glans, and scrotal enhancement, where the evidence is stronger and HA’s reversibility provides a safety margin.

How to Choose the Right Next Step

A simple framework can guide the decision:

1. Identify the primary goal: girth, glans proportion, or scrotal appearance.
2. Check the evidence tier and FDA status of the relevant options above.
3. Review the realistic cost range, starting at $7,500 with syringe-based pricing.
4. Book a consultation for guidance specific to individual anatomy.

The practice’s deeper resources cover each path in more detail:

• Male Enhancement Procedures: technique-level detail
• Male Enlargement: girth-specific comparisons
• Cost breakdown: detailed pricing information
• Before/after galleries: age-restricted patient results

Men who are unsure which anatomical target applies to them will get a more reliable answer from a free consultation than from online content alone.

Conclusion: Making an Informed Decision in a Category Full of Noise

This guide uses a three-part framework: anatomical target (shaft, glans, scrotum), evidence tier (from randomized-trial-backed HA filler to fat grafting that medical societies discourage), and transparent, syringe-based US pricing starting at $7,500.

Legitimacy in this category can be checked. FDA clearance status, published clinical data, and medical-society guidance are verifiable facts, not marketing claims, and this guide was written to make them easy to find. A trustworthy provider discloses off-label status, cites independent risk data, and declines procedures it does not consider safe, including surgical lengthening.

Ready to Discuss Your Options? Schedule a Free, Confidential Consultation

General online information can only go so far. A free consultation with a board-certified physician provides a recommendation based on an individual’s anatomy and goals.

The practice offers several assurances for privacy-conscious professionals:

• Discreet locations in Manhattan, Long Island, Albany, Pennsylvania, and Minnesota
• Fully confidential consultations
• Staged, conservative treatment planning instead of one-size-fits-all packages

Men ready to take the next step can request a free consultation online, or explore the procedure-specific pages linked throughout this hub before booking.